Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CASI Pharmaceuticals Inc.

    NASDAQ: CASI · Real-Time Price · USD
    1.86
    -0.01 (-0.54%)
    At close: Jun 06, 2025, 3:53 PM
    1.80
    -3.32%
    After-hours: Jun 06, 2025, 04:24 PM EDT

    CASI Pharmaceuticals Statistics

    Share Statistics

    CASI Pharmaceuticals has 15.49M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 15.49M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 11.14%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 317

    FTD / Avg. Volume

    n/a
    		 3.33%

    Short Selling Information

    The latest short interest is 16.88K, so 0.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 16.88K

    Short % of Shares Out

    n/a
    		 0.11%

    Short % of Float

    n/a
    		 0.14%

    Short Ratio (days to cover)

    n/a
    		 2.48

    Valuation Ratios

    The PE ratio is -1.11 and the forward PE ratio is -1.16. CASI Pharmaceuticals's PEG ratio is -0.04.

    PE Ratio

    n/a
    		 -1.11

    Forward PE

    n/a
    		 -1.16

    PS Ratio

    n/a
    		 1.52

    Forward PS

    n/a
    		 2.6

    PB Ratio

    n/a
    		 23.45

    P/FCF Ratio

    n/a
    		 -1.47

    PEG Ratio

    n/a
    		 -0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CASI Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.09, with a Debt / Equity ratio of 11.96.

    Current Ratio

    n/a
    		 1.09

    Quick Ratio

    n/a
    		 0.94

    Debt / Equity

    n/a
    		 11.96

    Debt / EBITDA

    n/a
    		 -0.64

    Debt / FCF

    n/a
    		 -0.75

    Interest Coverage

    n/a
    		 -45.49

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $122,476.39

    Profits Per Employee

    n/a
    		 $-168,489.27

    Employee Count

    n/a
    		 233

    Asset Turnover

    n/a
    		 0.53

    Inventory Turnover

    n/a
    		 3.31

    Taxes

    Income Tax

    n/a
    		 1.19M

    Effective Tax Rate

    n/a
    		 -3.12%

    Stock Price Statistics

    The stock price has increased by -48.91% in the last 52 weeks. The beta is 0.63, so CASI Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.63

    52-Week Price Change

    n/a
    		 -48.91%

    50-Day Moving Average

    n/a
    		 1.96

    200-Day Moving Average

    n/a
    		 3.68

    Relative Strength Index (RSI)

    n/a
    		 46.54

    Average Volume (20 Days)

    n/a
    		 9,522

    Income Statement

    In the last 12 months, CASI Pharmaceuticals had revenue of 28.54M and earned -39.26M in profits. Earnings per share was -2.56.

    Revenue

    n/a
    		 28.54M

    Gross Profit

    n/a
    		 11.15M

    Operating Income

    n/a
    		 -39.62M

    Net Income

    n/a
    		 -39.26M

    EBITDA

    n/a
    		 -34.87M

    EBIT

    n/a
    		 -37.2M

    Earnings Per Share (EPS)

    n/a
    		 -2.56
    Full Income Statement

    Balance Sheet

    The company has 13.47M in cash and 22.14M in debt, giving a net cash position of -8.67M.

    Cash & Cash Equivalents

    n/a
    		 13.47M

    Total Debt

    n/a
    		 22.14M

    Net Cash

    n/a
    		 -8.67M

    Retained Earnings

    n/a
    		 -700.08M

    Total Assets

    n/a
    		 53.67M

    Working Capital

    n/a
    		 3.12M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.22M and capital expenditures -240K, giving a free cash flow of -29.46M.

    Operating Cash Flow

    n/a
    		 -29.22M

    Capital Expenditures

    n/a
    		 -240K

    Free Cash Flow

    n/a
    		 -29.46M

    FCF Per Share

    n/a
    		 -1.92
    Full Cash Flow Statement

    Margins

    Gross margin is 39.06%, with operating and profit margins of -138.84% and -137.57%.

    Gross Margin

    n/a
    		 39.06%

    Operating Margin

    n/a
    		 -138.84%

    Pretax Margin

    n/a
    		 -133.4%

    Profit Margin

    n/a
    		 -137.57%

    EBITDA Margin

    n/a
    		 -122.18%

    EBIT Margin

    n/a
    		 -138.84%

    FCF Margin

    n/a
    		 -103.25%

    Dividends & Yields

    CASI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CASI is $4, which is 112.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $4

    Price Target Difference

    n/a
    		 112.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 2, 2022. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 2, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -19.59

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist